Both IGF-I and free testosterone are positively associated with prostate cancer risk in observational and Mendelian randomisation studies [4, 5]; however, men with obesity have moderately lower concentrations of IGF-I and free testosterone than men with a healthy BMI [45, 46]. This evidence concerns the gene IGF1 and prostate cancer.